companydata.dkcompanydata.dk

Rangers Pharmaceutical A/S: Financial statements 2020

CVR: 40381015

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -301,553 and a net result of DKK -4,065,623. Equity in the 2020 report amounted to DKK -829,383. The company had 1 employee in the financial year.

Gross Profit
DKK -301,553
Profit/Loss
DKK -4,065,623
Equity
DKK -829,383
Total Assets
DKK 46,309
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Rangers Pharmaceutical A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Clifford Starke joins the board of Rangers Pharmaceutical A/SOct 27, 2020

As of October 27, 2020, Clifford Starke has joined the board of directors of Rangers Pharmaceutical A/S.

Thileepan Ananthakumaran joins the board of Rangers Pharmaceutical A/SOct 27, 2020

As of October 27, 2020, Thileepan Ananthakumaran has joined the board of directors of Rangers Pharmaceutical A/S.

Clifford Starke joins Rangers Pharmaceutical A/S as directorOct 27, 2020

As of October 27, 2020, Clifford Starke is registered as director of Rangers Pharmaceutical A/S.

Clifford Starke leaves the board of Rangers Pharmaceutical A/SOct 26, 2020

As of October 26, 2020, Clifford Starke has left the board of directors of Rangers Pharmaceutical A/S.

Heinz Kvottrup Lorentzen leaves the board of Rangers Pharmaceutical A/SOct 22, 2020

As of October 22, 2020, Heinz Kvottrup Lorentzen has left the board of directors of Rangers Pharmaceutical A/S.

Peter Møller Lassen leaves the board of Rangers Pharmaceutical A/SOct 22, 2020

As of October 22, 2020, Peter Møller Lassen has left the board of directors of Rangers Pharmaceutical A/S.

Peter Møller Lassen steps down as director of Rangers Pharmaceutical A/SOct 22, 2020

As of October 22, 2020, Peter Møller Lassen has stepped down as director of Rangers Pharmaceutical A/S.

Rangers Pharmaceutical A/S publishes interim reportSep 14, 2020

Rangers Pharmaceutical A/S has published its interim report for the period March 26, 2019 to December 31, 2019.

Rangers Pharmaceutical A/S appoints new auditorFeb 7, 2020

As of February 7, 2020, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Rangers Pharmaceutical A/S.

Auditor steps down at Rangers Pharmaceutical A/SFeb 7, 2020

As of February 7, 2020, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Rangers Pharmaceutical A/S.

About Rangers Pharmaceutical A/S

Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.

Source: annual report 2025, Danish Business Authority

Other financial years